Performance Evaluation of Diagnostic Accuracy of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population and in Cancer Free Population.
NCT06456216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2024-06-13
Summary
Performance evaluation of diagnostic accuracy (Sensitivity and Specificity) of PanTum detect Test for detection of solid tumours in known cancer population (Sick population) and in cancer free (Healthy) population.
Conditions
Sponsors & Collaborators
-
Max Healthcare Insititute Limited
lead OTHER
Principal Investigators
-
Harit Chaturvedi, MCH · Max Super Speciality Hospital, Saket
Eligibility
- Min Age
- 30 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-21
- Primary Completion
- 2022-11-14
- Completion
- 2023-10-20
Countries
- India
Study Locations
More Related Trials
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED
-
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
NCT06756217 ·Status: RECRUITING
-
NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy
NCT04636047 ·Status: UNKNOWN
-
To Identify Potential New Urine Marker Panel for Cancer Screening
NCT04689802 ·Status: RECRUITING
-
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
NCT02146170 ·Status: RECRUITING
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
Integrative Analysis of Large-cell Lung Cancer
NCT02917369 ·Status: RECRUITING
-
Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC
NCT06111807 ·Status: RECRUITING
-
The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor
NCT04405557 ·Status: ACTIVE_NOT_RECRUITING
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Rarecells Molecular Biomarkers for Early Detection of Lung Cancer
NCT06546007 ·Status: RECRUITING
-
Consistency of PD-L1 Detecting Method Between E1L3N and 22C3 Monoclonal Antibodies in NSCLC Patients
NCT05129462 ·Status: COMPLETED
-
Evaluation of Clinical Significance and Feasibility of CT Guided Biopsy of Double Site Lesions:A Preliminary Lung Centered Study
NCT04960631 ·Status: COMPLETED
-
99mTc-H7ND SPECT/CT Imaging in NSCLC
NCT05999214 ·Status: RECRUITING ·Phase: NA
-
Cancer Panel From Blood of Lung Cancer Patients
NCT03235765 ·Status: UNKNOWN
-
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
NCT03320044 ·Status: COMPLETED
-
The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer
NCT06977386 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
Methylation-specific PCR Test for Early Screening and Early Diagnosis of Nasopharyngeal Carcinoma
NCT06367049 ·Status: COMPLETED
-
Radiogenomics in Aerodigestive Tract Cancers
NCT04314349 ·Status: COMPLETED
-
Procalcitonin Test for Differentiation of the Cause of Pneumonia
NCT03350802 ·Status: COMPLETED
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Tissue Collection Framework To Improve Outcomes In Solid Tumours
NCT03572192 ·Status: RECRUITING
-
Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
NCT05965024 ·Status: RECRUITING
-
Prospective Screening Programme for Malignant Tumors
NCT04230200 ·Status: UNKNOWN